Life Science Trends across Genetic Advances in Lung Cancer Detection and Treatment-Genetic Technology Alert

USD 250

* Required Fields

USD 250

PAY BY INVOICE

Be the first to review this product

This edition of the Genetic Alert depicts genetic advances in lung cancer detection and treatment. The study profiles a series of innovative technologies including genetic mutations identification, as well as, novel biomarkers and inhibitors. Analyst insights on genetic advances in lung cancer detection and treatment are included. The corresponding patent scenario is also depicted along with industry interactions.

The Genetic Alert presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants.

The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.

Keywords: active gene type, target identification, chemotherapy, genetic mutation inhibition, non-small cell lung cancer, genetic biomarkers

Table of Contents

Life Science Trends across Genetic Advances in Lung Cancer Detection and Treatment-Genetic Technology AlertTrend-based Technology ProfilesHighly Active Gene Type Responsible for Human Lung Cancer IdentifiedPotential Biomarker for Lung Cancer ChemotherapyNovel Cancer Therapy to Inhibit Genetic Mutation that Causes Non-small Cell Lung Cancer (NSCLC)Genetic Biomarker to Power Lung Cancer Diagnostic Blood TestStrategic PerspectivesAnalyst Insights on Genetic Advancements in Lung Cancer Detection and TreatmentAppendixPatent ScenarioPatent Scenario (continued)Industry Interactions




Related Research

Release Date : 19-May-17

Region : Global

Release Date : 12-May-17

Region : Global

Release Date : 12-May-17

Region : Global

Release Date : 12-May-17

Region : Global

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.